Sex-related differences in the risk factor profile and medications of patients with atrial fibrillation recruited in J-TRACE

Circulation Journal

Volumn 74, Issue 4, 2010, Pages 650-654

  Inoue, Hiroshi ^a   Nozawa, Takashi ^a   Hirai, Tadakazu ^a   Goto, Shinya ^b   Origasa, Hideki ^a   Shimada, Kazuyuki ^c   Uchiyama, Shinichiro ^d   Hirabayashi, Takayuki ^e   Koretsune, Yukihiro ^f   Ono, Shiro ^g   Hasegawa, Tooru ^h   Sasagawa, Yasuo ⁱ   Kaneko, Yoshiaki ^j   Ikeda, Yasuo ^k  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TOKAI UNIVERSITY   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e SUNAGAWA CITY MEDICAL CENTER   (Japan)

^f OSAKA NATIONAL HOSPITAL   (Japan)

^g Saiseikai Yamaguchi General Hospital   (Japan)

^h Hakodate Medical Association Hospital   (Japan)

ⁱ Sasagawa Medical Clinic   (Japan)

^j GUNMA UNIVERSITY   (Japan)

^k KEIO UNIVERSITY   (Japan)

more..

Author keywords

Atrial fibrillation; CHADS2 score; Clinical characteristics; Medications; Sex differences

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; TICLOPIDINE; WARFARIN;

ADULT; AGE; AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL FEATURE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE REGISTRY; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; RISK FACTOR; SEX DIFFERENCE; THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; ATRIAL FIBRILLATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; JAPAN; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PRESCRIPTION DRUGS; REGISTRIES; RISK FACTORS; SEX CHARACTERISTICS; THROMBOEMBOLISM; WARFARIN;

EID: 77950678025     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0802     Document Type: Article

References (30)

1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med 1995; 155: 469-473.
2. Go AS, Hylek EM, Phillips KA, Chang YC, Henoult LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: ational implications for rhythm management and stroke prevention: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. JAMA 2001; 285: 2370-2375.
3. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: Analysis of data from the general practice research database. Heart 2001; 86: 284-288.
4. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, et al. Prevalence of atrial fibrillation in the general population of Japan: An analysis based on periodic health examination. Int J Cardiol 2009; 137: 102-107.
5. Iguchi Y, Kimura K, Aoki J, Kobayashi K, Terasawa Y, Sakai K, et al. Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: Analysis of 41,436 non-employee residents in Kurashiki-City. Circ J 2008; 72: 909-913.
6. Humphries KH, Kerr CR, Connolly SJ, Klein G, Boone JA, Green M, et al. New-onset atrial fibrillation: Sex differences in presentation, treatment, and outcome. Circulation 2001; 103: 2365-2370.
7. Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation 2005; 112: 1687-1691.
8. Gomberg-Maitland M, Wenger NK, Feyzi J, Lengyel M, Volgman AS, Petersen P, et al. Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. Eur Heart J 2006; 27: 1947-1953
9. Dagres N, Nieuwlaat R, Vardas PE, Andersen D, Levy S, Cobbe S, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: A report from the Euro Heart Survey on atrial fibrillation. J Am Coll Cardiol 2007; 49: 572-577.
10. Kerr CR, Humphries K. Gender-related differences in atrial fibrillation. J Am Coll Cardiol 2005; 46: 1307-1308.
11. Friberg J, Scharling H, Gadsboll N, Truelsen T, Jensen GB. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (the Copenhagen City Heart Study). Am J Cardiol 2004; 94: 889-894.
12. Stewart S, Hart CL, Hole DJ, McMurray JJV. A population-based study of long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002; 113: 359-364.
13. Hart R, Pearce L, McBride R, Rothbart R, Asinger R. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: Analysis of 2012 participants in the SPAF I-III clinical trials. Stroke 1999; 30: 1223-1229.
14. Wang TJ, Massaro JM, Levy D, Vasa RS, Wolf PA, D'Agostino RB, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: The Framingham Heart Study. JAMA 2003; 290: 1049-1056
15. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Register of Atrial Fibrillation. JAMA 2001; 285: 2864-2870.
16. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449-1457
17. Origasa H, Goto S, Uchiyama S, Shimada K, Ikeda Y, on behalf of the J-TRACE Investigators. The Japan Thrombosis Registry for Atrial Fibrillation, Coronary or Cerebrovascular Events (J-TRACE): A nation-wide, prospective large cohort study; the study design. Circ J 2008; 72: 991-997
18. Uchiyama S, Shibata Y, Hirabayashi T, Mihara B, Hamashige N, Kitagawa K, et al For the J-TRACE Investigators. Risk factor profiles in patients with stroke, myocardial infarction, and atrial fibrillation: The Japan Thrombosis Registry for Atrial Fibrillation, Coronary r Cerebrovascular Events (J-TRACE). J Stroke Cerebrovasc Dis (in press).
19. Ohsawa M, Okayama A, Okamura T, Itai K, Nakamura M, Tanno K, et al for the NIPPON DATA80 Research Group. Mortality risk attributable to atrial fibrillation in middle-aged and elderly people in the Japanese general population: Nineteen-year follow-up in NIPPON DATA80. Circ J 2007; 71: 814-819.
20. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: The Hisayama Study. Stroke 2003; 34: 2349-2354.
21. Iso H, Sato S, Kitamura A, Imano H, Kiyama M, Yamagishi K, et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 2007; 38: 1744-1751.
22. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study. JAMA 1994; 271: 840-844
23. Fujishima M. Cardiac diseases as risk for cerebrovascular diseases. Junkanki Senmon-i 1998; 6: 19-26 (in Japanese)
24. Djousse L, Levy D, Benjamin EJ, Blease S, Russ A, Larson MG, et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham study. Am J Cardiol 2004; 93: 710-713.
25. Heerings J, Kors JA, Hofman A, van Rooij FJA, Witteman JCM. Cigarette smoking and risk of atrial fibrillation: The Rotterdam Study. Am Heart J 2008; 156: 1163-1169
26. Tse HF, Oral H, Pelosi F, Knight BP, Strickberger SA, Morady F. Effect of gender on atrial electrophysiologic changes induced by rapid atrial pacing and elevation of atrial pressure. J Cardiovasc Electrophysiol 2001; 12: 986-989.
27. Conway DS, Heeringa J, Van der Kuip DA, Chin BS, Hofman A, Witteman JC, et al. Atrial fibrillation and the prothrombotic state in the elderly: The Rotterdam study. Stroke 2003; 34: 413-417
28. Feinberg WM, Pearce LA, Hart RG, Cushman M, Cornell ES, Lip GY, et al. Markers of thrombin and platelet activity in patients with atrial fibrillation: Correlation with stroke among 1531 participants in the Stroke Prevention in Atrial Fibrillation III study. Stroke 1999; 30: 2547-2553
29. Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: A systematic review. Stroke 2009; 40: 1082-1090
30. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998; 352: 1167-1171